An Evidence-Based Review of Galcanezumab for the Treatment of Migraine
figureposted on 2020-10-01, 09:30 authored by Ivan Urits, Melis Yilmaz, Karina Charipova, Kyle Gress, Ehab Bahrum, Michael Swett, Amnon A. Berger, Hisham Kassem, Anh L. Ngo, Elyse M. Cornett, Alan D. Kaye, Omar Viswanath
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.